Skip to main content
. Author manuscript; available in PMC: 2018 Jul 23.
Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Apr 13;14(8):1199–1206.e2. doi: 10.1016/j.cgh.2016.03.046

Table 4.

ALFSG Model Performance According to Hepatic Encephalopathy HE) Grade and ALF Etiology (Validation Cohort)

HE Grade Etiology SS % Total Subjects Actual Equals Predicted Outcome % Correctly Predicted (SS or non-SS) Model Incorrectly Predicts Spontaneous Survival Model Incorrectly Predicts Negative Outcome (Death or LT) ††

Mild Favorable 85 209 135 64.6% 11(5.3%) 63 (30.1%)
Deep Favorable 55 278 157 56.5% 10 (3.6%) 111 (39.9%)
Mild Unfavorable 33 228 160 70.2% 0 (0.0%) 68 (29.8%)
Deep Unfavorable 21 170 135 79.4% 0 (0%) 35 (20.6%)

Total 885* 587 66.3% 21 (2.4%) 277 (31.3%)
*

Predictor variables missing from 102/987 subjects leaving 885 for analysis.

Subjects in which the model incorrectly predicts spontaneous survival when death or LT occurs.

††

Subjects in which the model incorrectly predicts the negative outcome (death or LT) when spontaneous survival occurs.